Short description
Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions.
Description
Long Description: Aiolos Bio is a biotech company focused on developing therapies for respiratory diseases like asthma as well as other immune conditions. The company is initially focused on advancing AIO-001, a monoclonal antibody therapy for moderate-to-severe asthma that only requires dosing every 6 months. Aiolos Bio was founded by an accomplished team with decades of drug development experience and leadership in the biotech industry.
Last funding
Nopepepe
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
San Francisco, California, United States, North America
Founded on
January 1, 2023
Exited on
January 9
Non-profit?
No
Acquired?
No
Employees count
11-50
Investors
Noaccess, No Way, Noaccess, No Way, Noaccess
Sign in for full access
Founders
Khurem Farooq